Characterizing the Disease-Initiating Cell Population In a Murine Model of Jak2V617F+Myeloproliferative Neoplasm

被引：0
|
作者：
Mullally, Ann
Lane, Steven W. [2 ]
Poveromo, Luke
Al-Shahrour, Fatima
Kutok, Jeffery [1 ]
Ebert, Benjamin L. [3 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[2] Childrens Hosp, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [31] Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
    Marty, Caroline
    Lacout, Catherine
    Martin, Antoine
    Hasan, Salma
    Jacquot, Sylvie
    Birling, Marie-Christine
    Vainchenker, William
    Villeval, Jean-Luc
    BLOOD, 2010, 116 (05) : 783 - 787
  • [32] Evaluation of JAK2V617F mutation prevalence in myeloproliferative neoplasm by AS-RT-PCR
    Karimzadeh, P.
    Ghaffari, S. H.
    Chahardouli, B.
    Zaghal, A.
    Einollahi, N.
    Mousavi, S. A.
    Bahar, B.
    Dargahi, H.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    Togheh, G. R.
    Nadali, F.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 1 (02) : 38 - 42
  • [33] Stat3 Negatively Regulates Myeloproliferative Neoplasm Induced By Jak2V617F
    Yan, Dongqing
    Mohi, Golam
    BLOOD, 2013, 122 (21)
  • [34] The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm
    Sangkhae, Veena
    Etheridge, S. Leah
    Kaushansky, Kenneth
    Hitchcock, Ian S.
    BLOOD, 2014, 124 (26) : 3956 - 3963
  • [35] Crucial Role of Jak2V617f-positive Myeloproliferative Neoplasm in the Development of Aortic Aneurysm
    Yokokawa, Tetsuro
    Misaka, Tomofumi
    Kimishima, Yusuke
    Wada, Kento
    Minakawa, Keiji
    Sugimoto, Koichi
    Ishida, Takafumi
    Ikeda, Kazuhiko
    Takeishi, Yasuchika
    CIRCULATION, 2020, 142
  • [36] PREVALENCE OF JAK2V617F MUTATION AND ITS CLINICAL CORRELATION IN THAIS WITH MYELOPROLIFERATIVE NEOPLASM
    Chanprasert, S.
    Suksomyos, N.
    Maunpasitporn, C.
    Ponlapat, R.
    HAEMATOLOGICA, 2012, 97 : 643 - 643
  • [37] Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation
    Yasuda, Shunichiro
    Chiba, Momoko
    Nishitani, Rie
    Watanabe, Takako
    CLINICAL CASE REPORTS, 2024, 12 (04):
  • [38] A Murine Model with JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm
    Zhang, Haotian
    Yeware, Amar
    Lee, Sandy
    Zhan, Huichun
    BLOOD, 2021, 138
  • [39] A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm
    Zhang, Haotian
    Yeware, Amar
    Lee, Sandy
    Zhan, Huichun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm
    Pomicter, Anthony D.
    Eiring, Anna M.
    Senina, Anna V.
    Zabriskie, Matthew S.
    Marvin, James E.
    Prchal, Josef T.
    O'Hare, Thomas
    Deininger, Michael W.
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (07) : 537 - 545
12345